Publications by authors named "A Finkwagner"
Italian S3-Guideline on the treatment of Atopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).
Ital J Dermatol Venerol
June 2024
Article Synopsis
- A new guideline for atopic eczema was published in two parts in August and September 2022, based on the EuroGuiDerm standards, following extensive consensus conferences with experts from twelve European countries.
- The guideline incorporates recent evidence on new systemic medications, with an update released in October 2022.
- Italian dermatological societies adapted the original EuroGuiDerm guideline for the Italian healthcare context, adding specific notes to highlight regulations and recommendations from the Italian Ministry of Health and regional authorities.
SIDeMaST (Società Italiana di Dermatologia Medica, Chirurgica, Estetica e delle Malattie Sessualmente Trasmesse) contributed to the development of the present guideline on the systemic treatment of chronic plaque psoriasis. With the permission of EuroGuiDerm, SIDeMaST adapted the guideline to the Italian healthcare context to supply a reliable and affordable tool to Italian physicians who take care of patients affected by atopic dermatitis. The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual.
View Article and Find Full Text PDFItalian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA).
Ital J Dermatol Venerol
June 2024
Article Synopsis
- - SIDeMaST developed guidelines for treating chronic plaque psoriasis and adapted them for the Italian healthcare system, aiming to provide a dependable resource for doctors treating atopic dermatitis patients in Italy.
- - The guideline follows the EuroGuiDerm Manual and was created with the input of 29 experts from 12 European countries, involving four consensus conferences held between December 2020 and July 2021.
- - It includes comprehensive information on systemic therapies, discussing conventional immunosuppressants, biologics, and Janus kinase inhibitors, while the second part will focus on factors like diet, immunotherapy, and considerations for special patient groups.
The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. Twenty-nine experts (including clinicians and patient representatives) from 12 European countries participated.
View Article and Find Full Text PDFEuropean guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.
J Eur Acad Dermatol Venereol
September 2022
Article Synopsis
- A guideline on atopic eczema was created based on evidence and consensus from 29 experts across 12 European countries, following the EuroGuiDerm framework, with four consensus conferences held from December 2020 to July 2021.
- The first part of the guideline outlines its goals, target audience, and treatment recommendations, focusing on which patients need systemic therapies and detailing various systemic drugs such as immunosuppressives, biologics, and janus kinase inhibitors.
- The upcoming second part will cover a range of topics including environmental factors, diet, educational interventions, and special considerations for children, pregnant women, and those breastfeeding.